DiaMedica has appointed Reginald Bowerman as president and CEO. He is replacing Rick Pauls, who will continue as chairman of the board.
Neurobiological Technologies has appointed William Fletcher as the company's acting chief executive officer.
3SBio has appointed Bo Tan as its new chief financial officer.
Phase Forward says that its chief financial officer, Rodger Weismann, is stepping down June 1.
Nerites has appointed David Sneider as its new CFO.
Aerovance has named Babatunde A. Otulana, M.D., to the position of senior vice president and chief medical officer.
Gentel Biosciences has promoted G. Randall Durnell, Ph.D., to executive vice president and chief operating officer and hired Dan Clutter, Ph.D., as vice president of commercial development.
Sarma P. Duddu, Ph.D., has been appointed as general manager and vice president of drug delivery technologies of CIMA LABS.
Acura Pharmaceuticals has appointed Albert Brzeczko as its new vice president of technical affairs.
Synta Pharmaceuticals has appointed Vojo Vukovic as its new vice president of clinical research.
Dr. Erika Nemeth has been appointed operations manager of Synexus Hungary.
Matthew Schumaker was named BIO's managing director, federal government relations.
Inspire Pharmaceuticals elected Alan F. Holmer to its board of directors,
Varian said Monday it named president and CEO Garry W. Rogerson to the additional post of chairman.
LAB Research announced the nomination of Carl A. Spalding as chairman of its board of directors in replacement of Karsten Skydsgaard.
WuXi PharmaTech has appointed Stewart Hen and Ning Zhao to its board of directors.
Cytomedix has appointed Eric Winzer to its board of directors.
Progenics Pharmaceuticals has announced the appointment of Peter J. Crowley to its board of directors.
BioNovo named Jan Ake Gustafsson to its Scientific Advisory Board.
Agios Pharmaceuticals announced the appointment of Charles Sawyers, M.D., to its scientific advisory board.